<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Practical 1: Modelling Tuberculosis in the United Kingdom • biddmodellingcourse</title>
<!-- jquery --><script src="https://code.jquery.com/jquery-3.1.0.min.js" integrity="sha384-nrOSfDHtoPMzJHjVTdCopGqIqeYETSXhZDFyniQ8ZHcVy08QesyHcnOUpMpqnmWq" crossorigin="anonymous"></script><!-- Bootstrap --><link href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script><!-- Font Awesome icons --><link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-T8Gy5hrqNKT+hzMclPo118YTQO6cYprQmhrYwIiQ/3axmI1hQomh7Ud2hPOy8SP1" crossorigin="anonymous">
<!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../jquery.sticky-kit.min.js"></script><script src="../pkgdown.js"></script><!-- mathjax --><script src="https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <div class="container template-vignette">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="../index.html">biddmodellingcourse</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/practical_1.html">Practical 1: Modelling Tuberculosis in the United Kingdom</a>
    </li>
  </ul>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/bristolmathmodellers/biddmodellingcourse">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      
      </header><div class="row">
  <div class="col-md-9">
    <div class="page-header toc-ignore">
      <h1>Practical 1: Modelling Tuberculosis in the United Kingdom</h1>
                        <h4 class="author">Sam Abbott, Katy Turner</h4>
            
          </div>

    
    
<div class="contents">
<div id="exercise" class="section level2">
<h2 class="hasAnchor">
<a href="#exercise" class="anchor"></a>Exercise</h2>
<p>Develop a flow diagram for a model of Tuberculosis transmission in the United Kingdom. The model should aim to answer one or more of the following study questions.</p>
<ol style="list-style-type: decimal">
<li>What impact would a new point of care test for TB have?</li>
<li>An improved Tuberculosis vaccine has been developed, who should recieve it and when?</li>
<li>A new Tuberculosis treatment is available which reduces treatment time from 6 months to 3 months. Forecast the long term impact of this on incidence rates</li>
<li>Tuberculosis screening for all new migrants has been introduced, is this strategy likely to suceed.</li>
</ol>
<p>In your groups read through the Tuberculosis facts below, choose a study question, and discuss the model structure that would be appropriate to investigate it. Remember that your model should aim to be as parsimonious as possible and therefore should not try to capture the full complexity of Tuberculosis transmission in the UK. To get you started here is a flow diagram for a basic model of Tuberculosis transmission (based on <span class="citation">(Brooks-Pollock, Cohen, and Murray 2010)</span>):</p>
<div class="figure">
<img src="resources/SEIR_flow_diag.png" alt="Figure 1: A model of Tuberculosis transmission, including simple demographic processes"><p class="caption">Figure 1: A model of Tuberculosis transmission, including simple demographic processes</p>
</div>
</div>
<div id="tuberculosis-facts" class="section level2">
<h2 class="hasAnchor">
<a href="#tuberculosis-facts" class="anchor"></a>Tuberculosis facts</h2>
<div id="natural-history-of-tuberculosis" class="section level3">
<h3 class="hasAnchor">
<a href="#natural-history-of-tuberculosis" class="anchor"></a>Natural History of Tuberculosis</h3>
<ul>
<li>Mode of transmission</li>
<li>Latent/Active disease</li>
<li>Pulmonary/non-Pulomonary TB</li>
<li>Smear positive/Smear negative</li>
<li>Age specific mortality rates</li>
</ul>
</div>
<div id="known-risk-factors" class="section level3">
<h3 class="hasAnchor">
<a href="#known-risk-factors" class="anchor"></a>Known risk factors</h3>
<ul>
<li>HIV</li>
<li>Diabetes</li>
<li>Smoking</li>
<li>Low socioeconomic status</li>
<li>High density living</li>
</ul>
</div>
<div id="treatments-vaccines-and-tests" class="section level3">
<h3 class="hasAnchor">
<a href="#treatments-vaccines-and-tests" class="anchor"></a>Treatments, vaccines and tests</h3>
<div id="treatments" class="section level4">
<h4 class="hasAnchor">
<a href="#treatments" class="anchor"></a>Treatments</h4>
<ul>
<li>DOTs</li>
<li>Drugs available (timelime)</li>
<li>Drug resistant TB</li>
</ul>
</div>
<div id="vaccines" class="section level4">
<h4 class="hasAnchor">
<a href="#vaccines" class="anchor"></a>Vaccines</h4>
<ul>
<li>BCG vaccine</li>
<li><p>Vaccines in development ### Tuberculosis globally</p></li>
<li>Global incidence</li>
<li>Global mortality</li>
<li><p>Co-epidemic with HIV</p></li>
</ul>
</div>
</div>
<div id="tuberculosis-in-the-uk" class="section level3">
<h3 class="hasAnchor">
<a href="#tuberculosis-in-the-uk" class="anchor"></a>Tuberculosis in the UK</h3>
<ul>
<li>Incidence in the UK</li>
<li>Incidence rates</li>
<li>UK born/non-UK born</li>
<li>Urban areas/non-Urban areas</li>
</ul>
<p><img src="practical_1_files/figure-html/plot-incidence-1.png" width="3500"></p>
<table class="table">
<caption>Table 1:</caption>
<colgroup>
<col width="8%">
<col width="28%">
<col width="16%">
<col width="10%">
<col width="36%">
</colgroup>
<thead><tr class="header">
<th align="left">Year</th>
<th align="left">Intervention</th>
<th align="left">Type</th>
<th align="left">Line</th>
<th align="left">Detail</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="left">1921</td>
<td align="left">BCG</td>
<td align="left">Vaccination</td>
<td align="left"></td>
<td align="left">The first use of the Bacillus Calmette–Guérin (BCG) vaccine in humans, it remains the only vaccine against Tuberculosis (tb). Efficacy has been shown to vary depending on latitude (0-80%) and there is only strong evidence of protection for 10-15 years after vaccination.</td>
</tr>
<tr class="even">
<td align="left">1944</td>
<td align="left">Streptomycin</td>
<td align="left">Antibiotic</td>
<td align="left">Second</td>
<td align="left">The first antibiotic and the first bacterial agent against TB.</td>
</tr>
<tr class="odd">
<td align="left">1944</td>
<td align="left">4-Aminosalicylic acid</td>
<td align="left">Antibiotic</td>
<td align="left">Second</td>
<td align="left">The second antiobiotic to be developed. Due to lower potency than other antibiotics it is not considered a first line treatment.</td>
</tr>
<tr class="even">
<td align="left">1952</td>
<td align="left">Isoniazid</td>
<td align="left">Antibiotic</td>
<td align="left">First</td>
<td align="left">Used against both active and latent TB, it may also be given as a prophylatic therapy.</td>
</tr>
<tr class="odd">
<td align="left">1952</td>
<td align="left">Cycloserine</td>
<td align="left">Antibiotic</td>
<td align="left">Second</td>
<td align="left">An antibiotic with severe side effects such as kidney failure and neurological conditions, which is therefore restricted for use against multiple drug resistant Tuberculosis.</td>
</tr>
<tr class="even">
<td align="left">1953</td>
<td align="left">School age BCG</td>
<td align="left">Vaccination</td>
<td align="left"></td>
<td align="left">After a successful trial, which showed high effectiveness for the vaccine, BCG was introduced for those at school leaving age as peak incidence was then in young, working-adults.</td>
</tr>
<tr class="odd">
<td align="left">1962</td>
<td align="left">Ethambutol</td>
<td align="left">Antibiotic</td>
<td align="left">First</td>
<td align="left">Believed to work by interfering with TB bacteria’s metabolism. There are some concerns that it may not be safe to give during pregancy, as it may lead to vision loss in the baby.</td>
</tr>
<tr class="even">
<td align="left">1971</td>
<td align="left">Rifampicin</td>
<td align="left">Antibiotic</td>
<td align="left">First</td>
<td align="left">Taken daily for at least a period of 6 months, if given alone resistance develops quickly. It may also be used in the treatment of MRSA amongst other diseases.</td>
</tr>
<tr class="odd">
<td align="left">1995</td>
<td align="left">DOTS</td>
<td align="left">Strategy</td>
<td align="left"></td>
<td align="left">Directly Observed Treatment, Short-Course (DOTS) is introdued by the World Health Organisation as a control strategy for TB. The intermittent, supervised system aims to eliminate drug default.</td>
</tr>
<tr class="even">
<td align="left">2005</td>
<td align="left">Neonatal high risk BCG</td>
<td align="left">Vaccination</td>
<td align="left"></td>
<td align="left">Due to a continued decline in TB incidence rates in the indigenous UK population, the BCG programme was refocused as risk-based. This meant vaccinating high risk neonates rather than those most likely to transmit TB.</td>
</tr>
<tr class="odd">
<td align="left">2012</td>
<td align="left">Bedaquiline</td>
<td align="left">Antibiotic</td>
<td align="left">Second</td>
<td align="left">The first new antiobiotic for use against TB in 40 years, reserved for use against multiple drug resistant TB. Approved via a fast track process there is still significant concern due to higher mortality in those that recieve the antibiotic.</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="references" class="section level2 unnumbered">
<h2 class="hasAnchor">
<a href="#references" class="anchor"></a>References</h2>
<div id="refs" class="references">
<div id="ref-Brooks-Pollock2010">
<p>Brooks-Pollock, Ellen, Ted Cohen, and Megan Murray. 2010. “The impact of realistic age structure in simple models of tuberculosis transmission.” <em>PLoS One</em> 5 (1): 3–8. doi:<a href="https://doi.org/10.1371/journal.pone.0008479">10.1371/journal.pone.0008479</a>.</p>
</div>
</div>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="sidebar">
        <div id="tocnav">
      <h2 class="hasAnchor">
<a href="#tocnav" class="anchor"></a>Contents</h2>
      <ul class="nav nav-pills nav-stacked">
<li><a href="#exercise">Exercise</a></li>
      <li><a href="#tuberculosis-facts">Tuberculosis facts</a></li>
      <li><a href="#references">References</a></li>
      </ul>
</div>
      </div>

</div>


      <footer><div class="copyright">
  <p>Developed by Sam Abbott, Josephine Walker, Ellen Brooks-Pollock.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="http://hadley.github.io/pkgdown/">pkgdown</a>.</p>
</div>

      </footer>
</div>

  </body>
</html>
